EE285 Cost-Effectiveness of Evolocumab Versus Standard Therapy for the Treatment of Dyslipidemia in Patients with Cardiovascular Disease in Qatar
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.530
https://www.valueinhealthjournal.com/article/S1098-3015(22)00731-8/fulltext
Section Title :
Section Order :
10473
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00731-8&doi=10.1016/j.jval.2022.04.530